Insider Transactions in Q4 2024 at Guardant Health, Inc. (GH)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 18
2024
|
Musa Tariq Director |
SELL
Open market or private sale
|
Direct |
116
-3.96%
|
$3,944
$34.85 P/Share
|
Dec 15
2024
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
323
-1.72%
|
$10,982
$34.76 P/Share
|
Dec 15
2024
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
637
+3.29%
|
-
|
Dec 15
2024
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
69
+0.5%
|
-
|
Dec 15
2024
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
535
-1.57%
|
$18,190
$34.76 P/Share
|
Dec 15
2024
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,020
+2.9%
|
-
|
Dec 15
2024
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
711
-2.88%
|
$24,174
$34.76 P/Share
|
Dec 15
2024
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,402
+5.38%
|
-
|
Dec 15
2024
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
597
-1.82%
|
$20,298
$34.76 P/Share
|
Dec 15
2024
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,402
+4.09%
|
-
|
Dec 15
2024
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+7.87%
|
-
|
Dec 15
2024
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,659
-6.07%
|
$56,406
$34.76 P/Share
|
Dec 15
2024
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,272
+5.79%
|
-
|
Dec 13
2024
|
Musa Tariq Director |
SELL
Open market or private sale
|
Direct |
2,320
-46.44%
|
$81,200
$35.0 P/Share
|
Dec 04
2024
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
67
+0.87%
|
-
|
Dec 02
2024
|
Meghan V. Joyce Director |
SELL
Open market or private sale
|
Direct |
100
-1.31%
|
$3,500
$35.9 P/Share
|
Dec 01
2024
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
360
-1.95%
|
$12,600
$35.61 P/Share
|
Dec 01
2024
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
710
+3.7%
|
-
|
Dec 01
2024
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
138
-0.42%
|
$4,830
$35.61 P/Share
|
Dec 01
2024
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
263
+0.79%
|
-
|
Dec 01
2024
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
161
-0.29%
|
$5,635
$35.61 P/Share
|
Dec 01
2024
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
316
+0.57%
|
-
|
Nov 30
2024
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
154
+1.51%
|
-
|
Nov 18
2024
|
Kumud Kalia Chief Information Officer |
SELL
Open market or private sale
|
Direct |
7,000
-28.29%
|
$203,000
$29.25 P/Share
|
Nov 15
2024
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
68
+0.5%
|
-
|
Nov 15
2024
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+4.77%
|
-
|
Nov 13
2024
|
Meghan V. Joyce Director |
SELL
Open market or private sale
|
Direct |
2,896
-27.47%
|
$83,984
$29.9 P/Share
|
Nov 12
2024
|
Ian T Clark Director |
BUY
Other acquisition or disposition
|
Indirect |
8,435
+50.0%
|
-
|
Nov 12
2024
|
Ian T Clark Director |
SELL
Other acquisition or disposition
|
Direct |
8,435
-100.0%
|
-
|
Nov 12
2024
|
Ian T Clark Director |
SELL
Open market or private sale
|
Direct |
8,318
-26.31%
|
$241,222
$29.48 P/Share
|
Nov 12
2024
|
Ian T Clark Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,076
+6.04%
|
$4,304
$4.18 P/Share
|
Nov 04
2024
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,945
-8.3%
|
$113,735
$23.6 P/Share
|
Nov 04
2024
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,756
+14.07%
|
-
|
Nov 04
2024
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66
+0.62%
|
-
|
Oct 31
2024
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
154
+1.53%
|
-
|
Oct 15
2024
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
69
+0.51%
|
-
|
Oct 15
2024
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+5.0%
|
-
|
Oct 04
2024
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66
+0.63%
|
-
|
Oct 01
2024
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,824
-10.4%
|
$84,128
$22.12 P/Share
|
Oct 01
2024
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,543
+9.14%
|
-
|
Oct 01
2024
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,009
-7.45%
|
$88,198
$22.12 P/Share
|
Oct 01
2024
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,908
+6.82%
|
-
|
Oct 01
2024
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,200
-15.29%
|
$92,400
$22.12 P/Share
|
Oct 01
2024
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,284
+13.44%
|
-
|
Oct 01
2024
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,620
-10.32%
|
$79,640
$22.12 P/Share
|
Oct 01
2024
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,498
+11.06%
|
-
|
Oct 01
2024
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,980
-10.75%
|
$65,560
$22.12 P/Share
|
Oct 01
2024
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,877
+9.88%
|
-
|
Oct 01
2024
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,162
-14.74%
|
$91,564
$22.12 P/Share
|
Oct 01
2024
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,211
+22.53%
|
-
|